INTRODUCTION: The Schwab-SRS Classification of Adult Spinal Deformity (ASD) is a validated system that provides a common language for the complex pathology of ASD. Classification reliability has been reported; however, correlation with treatment has not been assessed. Purpose: assess association between disability, classification type/modifier and ASD treatment. METHODS: Prospective analysis of consecutive ASD patients from a multi-center spinal deformity study group. Inclusion criteria: age = 18 yrs and scoliosis = 20°, sagittal vertical axis (SVA) = 5 cm, pelvic tilt (PT) = 25° or thoracic kyphosis (TK)> 60°. All patients had 36" standing x-rays. Differences in demographics, health related quality of life (HRQOL; ODI, SRS, SF36), and classification curve type/modifier distribution between operative (OP) and nonoperative (NONOP) treatment were evaluated. RESULTS: 757 patients (mean age 53 yrs, range 18-85) met inclusion criteria. OP (n = 311) were older (mean age 56 vs 51 yrs), had greater BMI (27.7 vs 25.7), more previous surgery (45% vs 19%), and greater Charlson comorbidity index (1.1 vs 0.85) than NONOP (n = 446), respectively (P < 0.05). OP had worse HRQOL scores on all surveys than NONOP (P < 0.05). OP and NONOP had similar coronal alignment (P < 0.05). OP had worse sagittal spinopelvic alignment for all measures than NONOP except cervical lordosis, TK and pelvic incidence (PI). OP had greater percentage of pure sagittal classification (type S; OP = 23%, NON = 14%; P < 0.05). OP had worse grades for all modifier categories: PT (26% vs 16%), PI-lumbar lordosis mismatch (37% vs 21%) and global sagittal alignment (29% vs 9%), OP vs NONOP, respectively (P < 0.05). CONCLUSION: Prospective analysis of OP vs NONOP treated ASD patients demonstrated OP patients were older, had more co-morbidities, greater disability and worse sagittal spinopelvic alignment as defined by the Schwab-SRS Classification subtype and sagittal modifiers. This classification is descriptive, correlates with HRQOL scores, and corresponds to treatment preference for ASD.
Read full abstract